Phosphorylated AMPK expression was associated with longer colorectal cancer-specific survival (log-rank P=0.0006) among p-MAPK3/1-positive cases, whereas p-AMPK expression was not significantly associated with survival among p-MAPK3/1-negative cases (log-rank P=0.45). Here, PRKAA2 is linked to colorectal cancer.